{
  "symbol": "UNH",
  "year": 2024,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.1962,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.186
  },
  "top_positive": [
    {
      "sent": "FINANCIAL STATEMENTS UnitedHealth Group Condensed Consolidated Balance Sheets (Unaudited) (in millions, except per share data) September 30, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 32,400 $ 25,427 Short-term investments 4,734 4,201 Accounts receivable, net 20,024 21,276 Other current receivables, net 27,461 17,694 Assets under management \u2014 3,755 Prepaid expenses and other current assets 7,639 6,084 Total current assets 92,258 78,437 Long-term investments 48,689 47,609 Property, equipment and capitalized software, net 10,139 11,450 Goodwill 105,978 103,732 Other intangible assets, net 23,594 15,194 Other assets 18,651 17,298 Total assets $ 299,309 $ 273,720 Liabilities, redeemable noncontrolling interests and equity Current liabilities: Medical costs payable $ 33,951 $ 32,395 Accounts payable and accrued liabilities 33,080 31,958 Short-term borrowings and current maturities of long-term debt 3,909 4,274 Unearned revenues 3,320 3,355 Other current liabilities 27,305 27,072 Total current liabilities 101,565 99,054 Long-term debt, less current maturities 74,101 58,263 Deferred income taxes 4,014 3,021 Other liabilities 15,174 14,463 Total liabilities 194,854 174,801 Commitments and contingencies (Note 8) Redeemable noncontrolling interests 4,574 4,498 Equity: Preferred stock, $ 0.001 par value - 10 shares authorized; no shares issued or outstanding \u2014 \u2014 Common stock, $ 0.01 par value - 3,000 shares authorized; 923 and 924 issued and outstanding 9 9 Additional paid-in capital 461 \u2014 Retained earnings 96,518 95,774 Accumulated other comprehensive loss ( 2,453 ) ( 7,027 ) Nonredeemable noncontrolling interests 5,346 5,665 Total equity 99,881 94,421 Total liabilities, redeemable noncontrolling interests and equity $ 299,309 $ 273,720 See Notes to the Condensed Consolidated Financial Statements 1 Table of Contents UnitedHealth Group Condensed Consolidated Statements of Operations (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, (in millions, except per share data) 2024 2023 2024 2023 Revenues: Premiums $ 77,442 $ 72,339 $ 232,327 $ 217,599 Products 12,631 10,354 36,751 31,272 Services 9,104 8,671 26,742 25,414 Investment and other income 1,643 997 3,651 2,910 Total revenues 100,820 92,361 299,471 277,195 Operating costs: Medical costs 65,957 59,550 197,150 179,663 Operating costs 13,280 13,855 40,519 41,289 Cost of products sold 11,834 9,423 34,230 28,576 Depreciation and amortization 1,041 1,007 3,058 2,998 Total operating costs 92,112 83,835 274,957 252,526 Earnings from operations 8,708 8,526 24,514 24,669 Interest expense ( 1,074 ) ( 834 ) ( 2,903 ) ( 2,416 ) Loss on sale of subsidiary and subsidiaries held for sale ( 20 ) \u2014 ( 8,331 ) \u2014 Earnings before income taxes 7,614 7,692 13,280 22,253 Provision for income taxes ( 1,356 ) ( 1,654 ) ( 3,822 ) ( 4,784 ) Net earnings 6,258 6,038 9,458 17,469 Earnings attributable to noncontrolling interests ( 203 ) ( 197 ) ( 596 ) ( 543 ) Net earnings attributable to UnitedHealth Group common shareholders $ 6,055 $ 5,841 $ 8,862 $ 16,926 Earnings per share attributable to UnitedHealth Group common shareholders: Basic $ 6.56 $ 6.31 $ 9.61 $ 18.20 Diluted $ 6.51 $ 6.24 $ 9.53 $ 18.01 Basic weighted-average number of common shares outstanding 923 926 922 930 Dilutive effect of common share equivalents 7 10 8 10 Diluted weighted-average number of common shares outstanding 930 936 930 940 Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 4 6 6 6 See Notes to the Condensed Consolidated Financial Statements 2 Table of Contents UnitedHealth Group Condensed Consolidated Statements of Comprehensive Income (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, (in millions) 2024 2023 2024 2023 Net earnings $ 6,258 $ 6,038 $ 9,458 $ 17,469 Other comprehensive income (loss): Gross unrealized gains (losses) on investment securities during the period 1,434 ( 893 ) 1,069 ( 684 ) Income tax effect ( 328 ) 204 ( 243 ) 156 Total unrealized gains (losses), net of tax 1,106 ( 689 ) 826 ( 528 ) Gross reclassification adjustment for net realized (gains) losses included in net earnings ( 291 ) 7 ( 349 ) ( 27 ) Income tax effect 67 ( 2 ) 80 6 Total reclassification adjustment, net of tax ( 224 ) 5 ( 269 ) ( 21 ) Foreign currency translation gains (losses) 88 ( 354 ) ( 197 ) 254 Reclassification adjustment for translation losses included in net earnings \u2014 \u2014 4,214 \u2014 Total foreign currency translation gains (losses) 88 ( 354 ) 4,017 254 Other comprehensive income (loss) 970 ( 1,038 ) 4,574 ( 295 ) Comprehensive income 7,228 5,000 14,032 17,174 Comprehensive income attributable to noncontrolling interests ( 203 ) ( 197 ) ( 596 ) ( 543 ) Comprehensive income attributable to UnitedHealth Group common shareholders $ 7,025 $ 4,803 $ 13,436 $ 16,631 See Notes to the Condensed Consolidated Financial Statements 3 Table of Contents UnitedHealth Group Condensed Consolidated Statements of Changes in Equity (Unaudited) Common Stock Additional Paid-In Capital Retained Earnings Accumulated Other Comprehensive Loss Nonredeemable Noncontrolling Interests Total Equity Three months ended September 30, (in millions) Shares Amount Net Unrealized (Losses) Gains on Investments Foreign Currency Translation (Losses) Gains Balance at June 30, 2024 921 $ 9 $ 373 $ 92,400 $ ( 2,296 ) $ ( 1,127 ) $ 5,317 $ 94,676 Net earnings 6,055 155 6,210 Other comprehensive income 882 88 970 Issuances of common stock, and related tax effects 4 \u2014 842 842 Share-based compensation 208 208 Common share repurchases ( 2 ) \u2014 ( 957 ) \u2014 ( 957 ) Cash dividends paid on common shares ($ 2.10 per share) ( 1,937 ) ( 1,937 ) Redeemable noncontrolling interests fair value and other adjustments ( 5 ) ( 5 ) Acquisition and other adjustments of nonredeemable noncontrolling interests 28 28 Distribution to nonredeemable noncontrolling interests ( 154 ) ( 154 ) Balance at September 30, 2024 923 $ 9 $ 461 $ 96,518 $ ( 1,414 ) $ ( 1,039 ) $ 5,346 $ 99,881 Balance at June 30, 2023 927 $ 9 $ \u2014 $ 89,994 $ ( 2,643 ) $ ( 5,007 ) $ 5,015 $ 87,368 Net earnings 5,841 149 5,990 Other comprehensive loss ( 684 ) ( 354 ) ( 1,038 ) Issuances of common stock, and related tax effects 1 \u2014 395 395 Share-based compensation 235 235 Common share repurchases ( 3 ) \u2014 ( 588 ) ( 923 ) ( 1,511 ) Cash dividends paid on common shares ($ 1.88 per share) ( 1,739 ) ( 1,739 ) Redeemable noncontrolling interests fair value and other adjustments ( 42 ) ( 42 ) Acquisition and other adjustments of nonredeemable noncontrolling interests 42 42 Distribution to nonredeemable noncontrolling interests ( 136 ) ( 136 ) Balance at September 30, 2023 925 $ 9 $ \u2014 $ 93,173 $ ( 3,327 ) $ ( 5,361 ) $ 5,070 $ 89,564 See Notes to the Condensed Consolidated Financial Statements 4 Table of Contents UnitedHealth Group Condensed Consolidated Statements of Changes in Equity (Unaudited) Common Stock Additional Paid-In Capital Retained Earnings Accumulated Other Comprehensive Loss Nonredeemable Noncontrolling Interests Total Equity Nine months ended September 30, (in millions) Shares Amount Net Unrealized (Losses) Gains on Investments Foreign Currency Translation (Losses) Gains Balance at January 1, 2024 924 $ 9 $ \u2014 $ 95,774 $ ( 1,971 ) $ ( 5,056 ) $ 5,665 $ 94,421 Net earnings 8,862 462 9,324 Other comprehensive income 557 4,017 4,574 Issuances of common stock, and related tax effects 7 \u2014 1,280 1,280 Share-based compensation 770 770 Common share repurchases ( 8 ) \u2014 ( 1,528 ) ( 2,517 ) ( 4,045 ) Cash dividends paid on common shares ($ 6.08 per share) ( 5,601 ) ( 5,601 ) Redeemable noncontrolling interests fair valu\n) $ 22,253 16 Table of Contents ITEM\u00a02.",
      "score": 0.9984
    },
    {
      "sent": "The following table summarizes the impact of hypothetical changes in market interest rates across the entire yield curve by 1% point or 2% points as of September\u00a030, 2024 on our investment income and interest expense per annum, and the fair value of our investments and debt (in millions, except percentages): September 30, 2024 Increase (Decrease) in Market Interest Rate Investment Income\u00a0Per Annum Interest Expense\u00a0Per Annum Fair\u00a0Value\u00a0of Financial Assets Fair\u00a0Value\u00a0of Financial Liabilities 2 % $ 824 $ 457 $ (3,773) $ (10,539) 1 412 229 (1,936) (5,745) (1) (412) (212) 2,015 7,016 (2) (824) (423) 4,083 15,514 Note: The impact of hypothetical changes in interest rates may not reflect the full 100 or 200 basis point change on interest income and interest expense or on the fair value of financial assets and liabilities as the rates are assumed to not fall below zero.",
      "score": 0.9876
    },
    {
      "sent": "The following table summarizes the impact of hypothetical changes in market interest rates across the entire yield curve by 1% point or 2% points as of September\u00a030, 2024 on our investment income and interest expense per annum, and the fair value of our investments and debt (in millions, except percentages): September 30, 2024 Increase (Decrease) in Market Interest Rate Investment Income\u00a0Per Annum Interest Expense\u00a0Per Annum Fair\u00a0Value\u00a0of Financial Assets Fair\u00a0Value\u00a0of Financial Liabilities 2 % $ 824 $ 457 $ (3,773) $ (10,539) 1 412 229 (1,936) (5,745) (1) (412) (212) 2,015 7,016 (2) (824) (423) 4,083 15,514 Note: The impact of hypothetical changes in interest rates may not reflect the full 100 or 200 basis point change on interest income and interest expense or on the fair value of financial assets and liabilities as the rates are assumed to not fall below zero.",
      "score": 0.9876
    }
  ],
  "top_negative": [
    {
      "sent": "It is 17 Table of Contents possible that future risks and uncertainties resulting from the Change Healthcare cyberattack, including risks related to impacted data, litigation, reputational harm, and regulatory actions could adversely affect our financial condition or results of operations.",
      "score": -0.8934
    },
    {
      "sent": "It is 17 Table of Contents possible that future risks and uncertainties resulting from the Change Healthcare cyberattack, including risks related to impacted data, litigation, reputational harm, and regulatory actions could adversely affect our financial condition or results of operations.",
      "score": -0.8934
    },
    {
      "sent": "It is 17 Table of Contents possible that future risks and uncertainties resulting from the Change Healthcare cyberattack, including risks related to impacted data, litigation, reputational harm, and regulatory actions could adversely affect our financial condition or results of operations.",
      "score": -0.8934
    }
  ],
  "forward_snippets": [
    "Readers are cautioned that the statements, estimates, projections or outlook contained in this Management's Discussion and Analysis of Financial Condition and Results of Operations, including discussions regarding financial prospects, economic conditions, trends and uncertainties contained in this Item\u00a02, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA).",
    "We expect to continue to incur direct response costs and experience business disruption impacts over the remainder of the year, which will continue at a lesser extent in 2025 as we work to bring transaction volumes back to pre-event levels and win new business.",
    "We expect overall spending on health care to continue to grow in the future, due to inflation, medical technology and pharmaceutical advancement, regulatory requirements, demographic trends in the population and national interest in health and well-being.",
    "We will continue seeking to balance growth and profitability across all these dimensions.",
    "We expect broad-based competition to continue as the industry adapts to individual and employer needs."
  ]
}